The HCPLive rheumatoid arthritis page is a comprehensive resource for clinical news and insights on arthritis. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for RA, and more.
May 16th 2024
A real-world study from Spain suggests baricitinib demonstrated favorable effectiveness, adherence, and safety in rheumatoid arthritis, but investigators caution more research is needed.
Women with Rheumatoid Arthritis at Greater Risk of Dying from Respiratory Disease
Women with rheumatoid arthritis are at greater risk for respiratory-related death than women without the disease, according to data presented at the 2014 American College of Rheumatology Annual Meeting.
Zoster Vaccination in Patients with Rheumatoid Arthritis: Time to Change the Recommendation?
November 19th 2014Administration of the varicella zoster vaccine is safe in patients with rheumatoid arthritis or other rheumatic conditions who are taking biologic disease-modifying anti-rheumatic drugs, according to study results presented at the 2014 American College of Rheumatology annual meeting.
Hydroxychloroquine Reduces Risk of Cardiovascular Events in Rheumatoid Arthritis
November 18th 2014The anti-arthritis drug hydroxychloroquine dramatically reduces the risk of cardiovascular morbidity and mortality in the disease, according to research presented here at the 2014 meeting of the American College of Rheumatology.
DMARD Discontinuation in RA: Feasible, but Questionable
November 11th 2014(ACR 2014) Encouraging real-life data to be presented at the ACR annual meeting suggest that at least some patients can safely discontinue biologics. But with the true meaning of remission still uncertain, it's not yet clear who they are.
New NIH Network Will Support Development of Novel Treatments for Rheumatoid Arthritis and Lupus
September 24th 2014The Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus Network is a public-private partnership designed to accelerate research into more effective diagnostic and treatment approaches for these autoimmune diseases.
Cartilage and its Role in Rheumatoid Arthritis
As any athlete or active person knows, the health of the cartilage in the knee can make the difference between comfortably moving around and pain that can stop you in your tracks. Researchers in Australia have recently discovered a stronger than expected link between knee cartilage and rheumatoid arthritis.
Which Biologic Therapy Is the Best Choice for Patients With Rheumatoid Arthritis?
September 15th 2014The choice of an appropriate disease-modifying antirheumatic drug (DMARD) is complicated by the availability of several agents and the lack of comparative effectiveness studies. Until recently, the scientific consensus did not favor any agent over another as the most appropriate initial biologic DMARD for patients with rheumatoid arthritis (RA).
The Multifaceted Pathogenesis of Rheumatoid Arthritis
September 12th 2014Although not completely understood, the pathogenesis of rheumatoid arthritis is thought to involve an external trigger (eg, trauma, cigarette smoke, infection) that induces an autoimmune reaction, resulting in synovial hypertrophy and chronic joint inflammation in persons who are genetically susceptible.
Cost Prevents Some Rheumatoid Arthritis Patients From Needed Prescriptions
For many patients with chronic conditions such as rheumatoid arthritis, medication adherence is often one of the most challenging aspects of the treatment process, especially when the medications prescribed by their health care professional are prohibitively expensive. A study from Manchester University recently showed that many patients with rheumatoid arthritis are not taking some of their most critical medicines due to rising drug costs.
Researchers Find 'Cure' for Rheumatoid Arthritis in Mice
Researchers at ETH Zurich who were studying mice with rheumatoid arthritis found a product that cured the animals of the condition as a precursor to what could be a much larger and beneficial discovery for humans. A statement from the company said the therapy is an "active substance consisting of two fused components."
Steps to Minimize Serious Risks of Biologic Treatment for Autoimmune Disease
July 19th 2014Although tumor necrosis factor inhibitors have dramatically improved management strategies for autoimmune disorders such as rheumatoid arthritis and inflammatory bowel disease, the biologic agents also pose a number of significant side effects that physicians must consider.
Targeting Inflammation in Diabetes through Disease-modifying Therapies
July 8th 2014An endocrinologist from the University Hospital Basel in Switzerland discusses the role of inflammation in the pathogenesis of type 2 diabetes, outlining the reasons why clinicians should target inflammation when treating diabetics.